SCHEMBL12378737

SCHEMBL12378737

Cc1ccc(C(c2ccc(Br)cc2)C(C)c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
HTR2A P28223 1/20 0.44
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD1 P21728 1/20 0.38
TBXA2R P21731 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
KEAP1 Q14145 3/20 0.38
NFE2L2 Q16236 3/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HTR7 P34969 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10628918 0.81 CYP2C19 (0.39) ALDH1A1LMNASMN1; SMN2SLC6A2SLC6A4
SCHEMBL12378742 0.81 LMNA (0.41) LMNASMN1; SMN2ADRA2AKEAP1NFE2L2
SCHEMBL6548164 0.80 LMNA (0.50) LMNASMN1; SMN2OPRM1KEAP1NFE2L2
SCHEMBL1973389 0.79 TAAR1 (0.44) ALDH1A1LMNAADRA2ATSHR
SCHEMBL12378749 0.77 ALDH1A1 (0.57) ALDH1A1LMNASMN1; SMN2KEAP1NFE2L2
SCHEMBL12378753 0.77 SMN1; SMN2 (0.45) LMNASMN1; SMN2KEAP1NFE2L2MEN1
SCHEMBL12199145 0.77 LMNA (0.53) LMNASMN1; SMN2OPRM1MEN1KMT2A
SCHEMBL17923689 0.77 LMNA (0.53) LMNASMN1; SMN2OPRM1MEN1KMT2A
SCHEMBL12378757 0.75 TDP1 (0.46) LMNASMN1; SMN2MEN1KMT2ATDP1
SCHEMBL12378739 0.75 CYP2D6 (0.56) ALDH1A1LMNASMN1; SMN2KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943200-B1 PARYLENE VARIANTS AND METHODS OF SYNTHESIS AND USE SPECIALTY COATING SYSTEMS INC (US) 2014-09-10 EP disclosed
US-7994372-B2 Parylene variants and methods of synthesis and use SPECIALTY COATING SYSTEMS, INC. (US) 2011-08-09 US disclosed
US-20090186998-A1 PARYLENE VARIANTS AND METHODS OF SYNTHESIS AND USE SPECIALTY COATING SYSTEMS, INC. (US) 2009-07-23 US disclosed
US-20090010870-A1 Hydrophobic Flourinated Polymer Surfaces PHILIPPS-UNIVERSITAT MARBURG (DE) 2009-01-08 US disclosed
US-7462750-B2 Parylene variants and methods of synthesis and use SPECIALTY COATING SYSTEMS, INC. (US) 2008-12-09 US disclosed
US-20070099019-A1 Parylene variants and methods of synthesis and use SPECIALTY COATING SYSTEMS, INC. (US) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090010870-A1 Hydrophobic Flourinated Polymer Surfaces HGF, PFN1, HACD3 ALDH1A1 2092/4885HTR2A 1175/4885LMNA 3788/4885
US-20070099019-A1 Parylene variants and methods of synthesis and use CDC73, PARN, PFAS ALDH1A1 3048/4885HTR2A 378/4885LMNA 514/4885
US-20090186998-A1 PARYLENE VARIANTS AND METHODS OF SYNTHESIS AND USE CDC73, PARN, PFAS ALDH1A1 2365/4885HTR2A 488/4885LMNA 632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.